The Percutaneous Transluminal Coronary Rotational Atherectomy Market size was estimated at USD 90.86 million in 2025 and expected to reach USD 104.56 million in 2026, at a CAGR of 12.71% to reach USD 210.07 million by 2032.

Percutaneous transluminal coronary rotational atherectomy is a lesion-preparation technique used to modify severely calcified coronary plaque before balloon angioplasty and stent implantation. By creating a smoother passage through rigid lesions, the procedure can support device delivery and improve stent expansion in selected patients. Its use is shaped by guideline recommendations, operator expertise, catheterization-laboratory capability, reimbursement, and the availability of alternative calcium-modification technologies. The central strategic issue is not routine substitution for standard percutaneous coronary intervention, but appropriate selection of complex lesions in which plaque modification may improve procedural feasibility and safety.

An aging population and the increasing prevalence of diabetes, chronic kidney disease, and diffuse atherosclerosis are contributing to a larger pool of patients with heavily calcified coronary lesions. Contemporary practice is also becoming more imaging-led: intravascular ultrasound and optical coherence tomography help characterize calcium distribution, thickness, and lesion length, enabling more selective device choice. Operators increasingly combine atherectomy with specialized balloons, intravascular imaging, and meticulous lesion preparation rather than treating the procedure as a standalone intervention. Training, credentialing, complication management, and disciplined procedural technique remain decisive because perforation, slow flow, and other complications can occur when rotational devices are used inappropriately.

Artificial intelligence is contributing indirectly to rotational atherectomy by improving cardiovascular risk identification, image interpretation, workflow prioritization, and post-procedure monitoring. Algorithms can assist with calcium detection and quantification in computed tomography or intravascular images, potentially helping clinicians identify lesions that merit advanced preparation. Decision-support tools may also integrate clinical history, renal function, lesion characteristics, and procedural data to support individualized planning. However, evidence for autonomous device selection or AI-directed atherectomy remains limited. Human oversight, prospective validation, transparent performance reporting, cybersecurity, and compliance with medical-device and clinical-governance requirements are essential before these tools influence high-risk procedural decisions.

North America combines advanced catheterization infrastructure, broad access to intravascular imaging, and established specialist training, while reimbursement and evidence requirements influence utilization. Europe emphasizes guideline-concordant care, health-technology assessment, and cross-country variation in procurement and access. Asia-Pacific spans highly sophisticated urban centers and settings where equipment, training, and referral pathways remain constrained; Japan, China, South Korea, India, and Australia therefore present distinct implementation conditions. Latin America is shaped by concentration of complex care in major cities, imported-device costs, and unequal insurance coverage. The Middle East shows strong investment in specialized hospitals in several markets, alongside workforce and referral differences. Africa continues to face substantial infrastructure, affordability, and specialist-access barriers, making regional centers and training partnerships particularly important.

ASEAN members differ materially in reimbursement, hospital capability, and regulatory maturity, so regional training and harmonized procurement can help address fragmentation. BRICS economies combine large patient populations with wide disparities between tertiary centers and lower-resourced facilities; domestic manufacturing, workforce development, and referral networks are relevant priorities. The European Union benefits from shared regulatory structures but retains national differences in payment and hospital purchasing. G7 systems generally have strong evidence-generation capacity and specialist infrastructure, while facing scrutiny over value, safety, and workforce efficiency. GCC countries are investing in advanced cardiovascular services and can serve as referral hubs, although dependence on imported expertise and equipment remains relevant. NATO members span diverse health systems, making interoperability, emergency readiness, and cross-border clinical standards more pertinent than a single adoption pattern.

Australia and Canada generally emphasize centralized specialist services, evidence-based utilization, and referral coordination across wide geographic areas. The United States has extensive interventional capability but faces variation in reimbursement, hospital resources, and operator-volume requirements. Brazil and Mexico show strong concentration of advanced procedures in major urban and private-sector centers, with public-system access remaining uneven. China and India are expanding complex cardiac-care capacity while managing major regional differences in infrastructure, affordability, and training. Japan, South Korea, Germany, France, Italy, Spain, and the United Kingdom have mature cardiovascular systems, but differ in procurement, reimbursement, waiting-list management, and the role of national or regional health authorities. Russia’s access is influenced by institutional concentration, supply-chain conditions, and uneven regional capacity. Across all countries, imaging availability, operator experience, emergency backup, and post-procedure care are central determinants of safe use.

Industry leaders should prioritize evidence-based patient selection, standardized procedural protocols, and robust training rather than pursuing indiscriminate utilization. Catheterization laboratories should establish clear criteria for intravascular imaging, calcium-modification choice, burr selection, anticoagulation, complication recognition, and escalation to surgical or mechanical support when needed. Health systems can improve value by tracking technical success, stent expansion, complications, repeat intervention, renal outcomes, and patient-reported recovery. Access strategies should account for total procedure requirements, including imaging, compatible guidewires, backup equipment, skilled personnel, and follow-up. Technology developers should focus on ergonomic improvements, interoperability with imaging and workflow systems, transparent evidence, and post-market surveillance. Partnerships with teaching hospitals and professional societies can expand competency without weakening credentialing standards.

This executive summary is based on a structured review framework for percutaneous rotational atherectomy, emphasizing authoritative clinical guidelines, peer-reviewed studies, regulatory materials, health-system publications, and publicly available epidemiological and infrastructure evidence. Findings are organized by clinical application, enabling technologies, geography, and health-system grouping. Interpretation distinguishes established clinical practice from emerging capabilities, especially for artificial intelligence. Geographic comparisons consider disease burden, catheterization-laboratory infrastructure, specialist workforce, reimbursement, procurement, and regulatory context. Because access and reporting vary across countries, qualitative conclusions are presented cautiously and should be validated against local guidelines, institutional data, and current regulatory requirements before operational decisions are made.

Rotational atherectomy remains a specialized tool for challenging calcified coronary lesions, with its value determined by appropriate patient selection, operator proficiency, imaging support, and the ability to manage complications. The field is moving toward integrated calcium assessment and lesion preparation, while AI is most immediately relevant to imaging, workflow, and quality improvement rather than autonomous intervention. Regional and country-level differences in infrastructure, reimbursement, training, and referral patterns will continue to shape access. Leaders who invest in competency, measurable outcomes, interoperable imaging, and equitable referral pathways will be better positioned to use the technique safely and consistently.